Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vital Therapies Inc (NASDAQ:VTL)

3.62
Delayed Data
As of Sep 02
 +0.32 / +9.70%
Today’s Change
2.81
Today|||52-Week Range
29.67
-85.48%
Year-to-Date

Today’s Trading

Previous close3.30
Today’s open3.31
Day’s range3.25 - 3.68
Volume464,588
Average volume (3 months)571,611
Market cap$79.3M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)-12.74%
Earnings growth (this year)+33.02%
Earnings growth (next 5 years)+10.27%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...-0.00-0.81%
PVCTProvectus Biopharmac...-0.01-3.03%
BOTABiota Pharmaceutical...-0.03-1.37%
BLRXBioLine RX Ltd+0.08+5.33%
Data as of 09/02/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$47.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Co-Chairman &
Chief Executive Officer
Terence E. Winters
Chief Financial Officer &
Treasurer
Michael V. Swanson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers